 NASHVILLE, TN ACCESSWIRE April 8, 2021 EV Biologics Corp OTC PINK:YECO today announced that it has signed a directors loan agreement to secure funding of up to 5 million to start generation of a novel exosome-producer cell line and production of therapeutic exosomes for preclinical research. The Company has finalized its preparation and is ready to begin generation of a novel exosome-producer master cell bank to enable manufacturing of therapeutic exosomes with improved intrinsic bioactivity at a commercially relevant scale. 